Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Covington
Express Scripts
Colorcon
Farmers Insurance
Merck
Boehringer Ingelheim
Medtronic
Julphar

Generated: April 25, 2018

DrugPatentWatch Database Preview

CEFPIRAMIDE SODIUM Drug Profile

« Back to Dashboard

Which patents cover Cefpiramide Sodium, and what generic alternatives are available?

Cefpiramide Sodium is a drug marketed by Wyeth Ayerst and is included in one NDA.

The generic ingredient in CEFPIRAMIDE SODIUM is cefpiramide sodium. There is one drug master file entry for this compound. Additional details are available on the cefpiramide sodium profile page.
Summary for CEFPIRAMIDE SODIUM
Drug patent expirations by year for CEFPIRAMIDE SODIUM
Synonyms for CEFPIRAMIDE SODIUM
(6R,7R)-7-((R)-2-(4-Hydroxy-6-methylnicotinamido)-2-(4-hydroxyphenyl)acetamido)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-((R)-2-(4-Hydroxy-6-methylnicotinamido)-2-(p-hydroxyphenyl)acetamido)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
(6R,7R)-7-[(2R)-2-[(4-hydroxy-6-methylpyridin-3-yl)formamido]-2-(4-hydroxyphenyl)acetamido]-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2R)-2-(4-hydroxyphenyl)-2-[(6-methyl-4-oxo-1H-pyridine-3-carbonyl)amino]acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2R)-2-{[(4-hydroxy-6-methylpyridin-3-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
137KB7GYKB
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((((4-hydroxy-6-methyl-3-pyridinyl)carbonyl)amino)(4-hydroxyphenyl)acetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7beta(R*)))-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((((4-hydroxy-6-methyl-3-pyridinyl)carbonyl)amino)(4-hydroxyphenyl)acetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, monosodium salt, (6R-(6alpha,7beta
70797-11-4
70797-11-4 (Parent)
74849-93-7
74849-93-7 (hydrochloride salt)
797C114
7beta-[(2R)-2-{[(4-hydroxy-6-methylpyridin-3-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetamido]-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid
849C937
AC1LCS6B
AK326203
AKOS025311237
AKOS025311239
AN-36970
Antibiotic SM 1652
AS-14170
C-23351
C13376
C25H23N8NaO7S2
C25H24N8O7S2
CAS-70797-11-4
CCG-221235
cefpiramide
Cefpiramide (USP/INN)
Cefpiramide [USAN:USP:INN]
Cefpiramide acid
Cefpiramide sodium (JP17/USAN)
Cefpiramide sodium [USAN:JAN]
Cefpiramide sodium salt
Cefpiramidesodium
Cefpiramido
Cefpiramido [INN-Spanish]
Cefpiramidum
Cefpiramidum [INN-Latin]
CHEBI:31377
CHEBI:59213
CHEMBL1200672
CHEMBL1201204
D01904
D03428
DB00430
DSSTox_CID_26630
DSSTox_GSID_46630
DSSTox_RID_81778
DTXSID6046630
HE385630
K197
K279
MFCD00864893
MolPort-023-220-334
MolPort-023-220-337
NCGC00167444-01
P936YA152N
SCHEMBL194379
SCHEMBL194380
SCHEMBL49253
Sepatren
SM-1652
Sodium (6R,7R)-7-((R)-2-(4-hydroxy-6-methylnicotinamido)-2-(p-hydroxyphenyl)acetamido)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
sodium (6R,7R)-7-{[(2R)-2-{[(4-hydroxy-6-methylpyridin-3-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Suncefal
Suncefal (TN)
Tamicin
Tox21_112448
UNII-137KB7GYKB
UNII-P936YA152N
WY 44
WY 44,635
WY 44,635 sodium
WY 44635
WY-44,635
WY-44,635 SODIUM
WY-44635
WY-44635 Sodium
ZINC4215257

US Patents and Regulatory Information for CEFPIRAMIDE SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst CEFPIRAMIDE SODIUM cefpiramide sodium INJECTABLE;INJECTION 050633-002 Jan 31, 1989 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Ayerst CEFPIRAMIDE SODIUM cefpiramide sodium INJECTABLE;INJECTION 050633-003 Jan 31, 1989 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Ayerst CEFPIRAMIDE SODIUM cefpiramide sodium INJECTABLE;INJECTION 050633-005 Jan 31, 1989 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
US Army
Healthtrust
McKesson
Fish and Richardson
Federal Trade Commission
Julphar
UBS
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.